The patient had gone out to dinner and eaten a meal that was not consistent with her usual low-salt diet and felt that she had an increase in peripheral edema following her Friday hemodialysis.
On arrival to the Emergency Room, the patient required mask ventilation, pressor support of 5, PEEP 5, and FI02 of 50%.
Ultimately, the patient was placed on a nitroglycerin drip and transitioned to 6 liters nasal cannula, saturating 97%.
Coronary artery disease, status post RCA stent in [**8-6**] with thrombus, re-stent stenosis in [**10-6**] with NSTEMI.
PhosLo 664 mg t.i.
Vitamin E. 3.
Vitamin C. 4.
Colace 100 mg p.o.
Aspirin 325 mg p.o.
Mirapex 0.25 mg p.o.
Pravachol 10 mg p.o.
Quinine 650 mg p.o.
Atacand 4 mg p.o.
NPH insulin 27 units q.a.m.
Chem-7 pertinent for potassium 5.4, BUN and creatinine 79 and 7.3 respectively.
Troponin 0.19.
IMPRESSION:  The patient was admitted to the MICU with a history of end-stage renal disease on hemodialysis and anuric who presents with shortness of breath.
Given the patient's prior significant coronary artery disease, continued on aspirin and Plavix and monitored with serial enzymes to rule out an ST elevation MI given positive troponins.
The patient was dialyzed on hospital day number one with resolution of her shortness of breath, continued to monitor troponins which reached a peak of 0.2.
The decision was made to take the patient the patient the Catheterization Laboratory where there was a discreet 80% lesion in the OM2 with a Taxol-eluding stent placed and a discreet 90% lesion in the RCA with balloon angioplasty and brachytherapy to the area.
The patient was continued on lifelong aspirin and Plavix and will increase the patient's Zocor from 5 mg p.o.
In discussion with the Renal Team, it was felt that the patient's dry weight goal could be decreased and to be further monitored as an outpatient, hemodialysis continued, calcium acetate and Nephrocaps as well as strict fluid and sodium restrictions.
HYPERTENSION:  The patient continued on beta blocker, Toprol XL, as well as ACE as managed as an outpatient.
FOLLOW-UP:  The patient is to follow-up with PCP in one to two weeks as well as Cardiology in one to two weeks to assess for weight, volume status, to continue on outpatient hemodialysis t.i.
